Desensitization therapy for allergic conjunctivitis in young people
Part of Eyes & vision, Immune system & allergy clinical trials.
This study looks at how allergy shots (desensitization therapy) affect the immune system in people with allergic conjunctivitis (eye allergy). It aims to see if this treatment can help reduce eye allergy symptoms by changing certain immune cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged between 5 and 30 years, male or female.
- Diagnosed with allergic conjunctivitis (eye allergy) and currently having symptoms.
- Positive skin test for allergies.
- No infection in the past 2 months.
- No other active allergic diseases like asthma or dermatitis.
- No chronic, autoimmune, or immunosuppressive treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how allergic reactions to cat or birch allergens affect people. It aims to find and describe adults and children with these allergies, which may help develop better treatments.
This trial tests a new eye drop to reduce itching and other symptoms of allergic conjunctivitis, a condition where the eyes become red, itchy, and uncomfortable due to allergies. It may help people who have not found relief with current treatments.
This trial tests an investigational eye drop called TL-925 to see if it can treat allergic conjunctivitis (eye allergies). If you have a history of eye allergies and a positive allergy skin test, you may be able to join.
This trial tests an injectable treatment that may help manage eye allergy symptoms caused by cat allergies. It aims to see if the treatment is safe and effective for adults and children, and includes a controlled cat exposure challenge.
This trial tests if allergy shots (allergen-specific immunotherapy) can reduce symptoms of moderate to severe dust mite allergy. You will be in a room that exposes you to dust mites to see how well the treatment works, compared to a placebo.
This trial tests an eye drop called Daydrop Triple Action to see if it helps with eye itching and redness caused by allergies. It might be a good option if you have allergic conjunctivitis and have not used other allergy eye medications recently.
Hear when a new Conjunctivitis, Allergic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.